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Angiotensin II stimulates endothelin- 1 secretion in cultured rat
mesangial cells
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Angiotensin II stimulates endothelin-1 secretion in cultured rat mesan-
gial cells. The present study was designed to test two hypotheses: (1)
that angiotensin II (Ang II) stimulates endothelin-1 secretion in cultured
rat mesangial cells and (2) that atrial and brain natriuretic peptides
(ANP and BNP) inhibit the above-mentioned secretion in these cells.
Ang II stimulated immunoreactive (ir) endothelin-1 secretion in a
concentration-dependent manner between l0- M and io M. The
protein kinase C (PKC) inhibitors from two chemical classes, H7 and
staurosporine, inhibited secretion following such stimulation. The stim-
ulatory effect of Ang II was also abolished in the PKC-depleted cells.
Rat ANP(l-28) and rat BNP-45, which are the respective major circu-
lating forms of ANP and BNP in rats, potently inhibited Ang II-
stimulated endothelin- I secretion in a concentration-dependent man-
ner. Inhibition by ANP and BNP of Ang Il-stimulated endothelin-l
secretion was paralleled by an increase in the cellular level of cyclic
guanosine 5'-monophosphate (GMP). The addition of a cyclic GMP
analogue, 8-bromo cyclic GMP, reduced the stimulated endothelin-l
secretion. Rat ANP(5-25) was less effective that rat ANP(l-28) with
respect to inhibiting ir-endothelin- I secretion and increasing cellular
cyclic GMP. These findings indicate that Ang IL stimulates endothelin-l
secretion in cultured rat mesangial cells by a mechanism probably
involving activation of PKC, and that rat ANP and BNP inhibit this
stimulated secretion through a cyclic GMP-dependent process.
Glomerular mesangial cells play a role in the regulation of
glomerular filtration rate through their contractility. These cells
have receptors specific to various vasoactive peptides such as
angiotensin II (Ang II) [1, 2], endothelin [3, 4] and atrial
natriuretic peptide (ANP) [5]. Stimulation by the above-men-
tioned vasoactive peptides results in contraction or relaxation
of the mesangial cells [6, 7], leading to the change in the
capillary surface area necessary for glomerular filtration [8].
Therefore, interactions among these peptides in glomerular
mesangial cells appear to be important for the regulation of
glomerular function. For example, ANP prevent the contractile
effect of Ang II in isolated glomeruli and cultured glomerular
mesangial cells [9, 10].
Endothelin-l is a vasoconstrictor peptide of 21 amino acids
that was first isolated from porcine vascular endothelial cells
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[11]. This peptide acts not only on vascular smooth muscle cells
[11, 12] but also on other cell types, including glomerular
mesangial cells [3, 13]. In cultured mesangial cells, endothelin-1
binds to its specific receptors, enhances phosphoinositide turn-
over, and induces the contraction and proliferation of these
cells [31. Recent studies demonstrated constitutive expression
of endothelin-1 transcripts and peptide secretion in cultured
mesangial cells and isolated glomeruli [14, 15]. On the other
hand, both Saijonmma, Ristimaki and Fyhrquist [16] and we
[17] have shown that ANP and brain natriuretic peptide (BNP),
which are respectively secreted predominantly from cardiac
atria and ventricles [18, 19], inhibit basal or Ang 11-stimulated
endothelin-l secretion in cultured endothelial cells. The present
study was therefore designed to test two hypotheses: (1) that
Ang II stimulates endothelin- 1 secretion in cultured rat mesan-
gial cells and (2) that ANP and BNP inhibit Ang Il-stimulated
secretion of endothelin-l in these cells.
Methods
Mesangial cell culture
Glomeruli were isolated from Sprague-Dawley rats weighing
50 to 100 g by sieving with stainless steel and nylon meshes
under sterile conditions as previously reported by Kikkawa et al
[20] and Haneda et al [21]. The isolated glomeruli were then
cultured in RPMI 1640 medium containing 20% fetal bovine
serum and antibiotics. The identity of the mesangial cells was
confirmed by the following criteria: (1) morphology; (2) typical
microfilaments seen by transmission electron microscopy; (3)
survival in a medium containing D-valine substituted for
L-valine, indicating the existence of D-amino acid oxidase; (4)
resistance to puromycin aminonucleoside (10 igIml) but sus-
ceptibility to mitomycin C (10 g/ml); (5) presence of receptors
specific to ANGII and contraction in response to Ang II; and (6)
absence of immunofluorescence with factor VIII antibody.
Cells after 3 to 7 passages were grown on 35-mm six-well plates
and were used for the experiment after confluency. The cultures
were maintained at 37°C with atmospheric air and 5% C02, and
subculture was carried out after treatment with Versine® fol-
lowed by trypsin.
Materials
Ang II, 8-bromo cyclic guanosine 5'-monophosphate (GMP)
and 3-isobutyl-1-methylxanthine (IBMX), phorbol myristate
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acetate (PMA) were purchased from Sigma Chemical Co. (St.
Louis, Missouri, USA). Staurosporine was purchased from
Calbiochem Corp. (La Jolla, California, USA). The protein
kinase C (PKC) inhibitor, H7, was purchased from Seikagaku
Kogyo Co. Ltd. (Tokyo, Japan). RPM! 1640, trypsin, Versene®
and fetal bovine serum were purchased from G!BCO Labora-
tories (Grand Island, New York, USA). Flasks were purchased
from Becton Dickinson and Co. (Oxnard, California, USA).
Endothelin-1, endothelin-2, endothelin-3, big endothelin-1 (por-
cine, 1-39), rat ANP(l-28) and rat BNP-45 were purchased from
Peptide Institute, Inc. (Osaka, Japan). Endothelin-I antiserum
and rat ANP(5-25) were purchased from Peninsula Laboratories
Inc. (Belmont, California, USA). '251-endothelin-l was pur-
chased from Amersham Japan Inc. (Tokyo, Japan). The cyclic
GMP assay kit was purchased from Yamasu Shoyu Co. Ltd.
(Chiba, Japan).
Pharmacological treatment
The culture medium was removed and the cell monolayers
were washed twice with serum-free RPM! 1640. Various sub-
stances such as ANP, BNP, sodium nitroprusside, H7, or
staurosporine were then added to the medium (except for the
controls), and the cells were incubated at 37°C under these
conditions. All of the experiments were performed with 2 ml of
serum-free RPM! 1640. After incubation, the medium was
aspirated and centrifuged at 3000 x g for 10 minutes, and the
supernatant was collected and stored at —80°C until radioim-
munoassay. Serum-free RPM! 1640 was used to avoid the
presence of hormones and enzymes that could have masked the
effects of the added pharmacological agents [22].
Extraction of ir-endothelin-1
ir-Endothelin-l was extracted as previously described [23,
24]. Briefly, 1.5 ml of each sample was diluted with 4 ml of 4%
acetic acid. After centrifugation, the solution was pumped at
the rate of 1 ml/min through a Sep-Pak C18 cartridge (Millipore
Corp., Milford, Massachusetts, USA). After evaporation of the
eluate with 86% ethanol in 4% acetic acid by a centrifugal
evaporator (Model RD-31, Yamato Scientific Co., Tokyo, Ja-
pan), the dry residue was dissolved in the assay buffer de-
scribed below. The recovery rate was found by adding three
different quantities of cold endothelin-1 (10, 50 and 100 pg/mI) to
serum-free RPM! 1640. Recovery was 69 2%.
Radioimmunoassay of endothelin-1
The ir-endothelin-1 concentration was assayed using endo-
thelin-1 antiserum and '25!-endothelin-1 as a tracer. This anti-
body reacts 100% with endothelin-l and cross reacts 7% with
endothelin-2, 7% with endothelin-3 and 35% with big endothe-
lin-l (porcine, 1-39). The antiserum did not cross react with rat
ANP(l-28) or -(5-25), rat BNP-45, somatostatin, f3-endorphin,
human secretin, Ang II or vasopressin.
Radioimmunoassay was performed in an assay buffer of 0.01
M sodium phosphate, pH 7.4, containing 0.05 M NaCI, 0.1%
bovine serum albumin, 0.1% Nonidet P-40 and 0.01% NaN3, as
previously described [23, 24]. !n brief, rehydrated antiserum
(100 d) was added to 100 d of the sample or 100 d of standard
endothelin-l dissolved in the assay buffer and the mixture was
incubated for 24 hours at 4°C. Approximately 15,000 cpm of
'251-endothelin-l was added to each reaction and incubated for
Table 1. Effect of Ang II on ir-endothelin-1 secretion i
mesangial cells
n cultured rat
ir-Endothelin-l level (pg/S X
with incubation of
iO cells)
24 hours 48 hours 72 hours
Baseline
Ang 1110
Ang I! 10
8 M
M
4.7 0.4 10.3 0.7
5.6 0.7° 15.2 1.1a
6.6 0.6° 18.3 1.2°
13.0 0.8
18.4 0.9
22.6 0.9°
Each value is the mean SD of assays made of six cell cultures.
a Significant difference compared with baseline level (P < 0.05)
an additional 24 hours. After this incubation, 100 1 of diluted
normal rabbit serum and 100 d of diluted goat anti-rabbit
immunoglobulin U were added and the mixture was again
incubated for 24 hours. After the third incubation, the precipi-
tate was collected by centrifugation at 1700 g for 30 minutes.
The supernatant was removed by aspiration and the pellet was
counted for 125! with a gamma counter. The interassay variation
was 13% and the intra-assay variation was 7%.
ANP, BNP and ANG!! did not interfere with the radioimmu-
noassay.
Cyclic GMP measurement
After preincubation, the cell monolayers were washed twice
with serum-free RPM! 1640 and then stimulated for 30 minutes
with different concentrations of ANP or BNP dissolved in
RPMI 1640 that contained 0.5 mivi !BMX, as previously re-
ported [17]. Rapid aspiration and the addition of 2 ml of ice-cold
65% ethanol stopped the reaction. Cyclic GMP levels were
determined by radioimmunoassay done with the cyclic GMP
assay kit.
Calculations and statistical analysis
The statistical significance of differences in the results was
evaluated by analysis of variance, and P values were calculated
by Scheffe's method [25]. Values are expressed as mean SD.
Results
Effects of Ang II on ir-endothelin-1 secretion in cultured rat
mesangial cells
Confluent cultured cells secreted ir-endothelin-l into the
medium in a time-dependent manner. Ang II stimulated ir-
endothelin-1 secretion in a concentration-dependent manner
(Table I). ir-Endothelin-1 secretion induced by Ang !! increased
during the initial 48 hours of incubation, after which the rate of
increase showed a slight but significant decline. Therefore, later
experiments on ir-endothelin-l secretion were performed with
cells incubated for 48 hours.
Effects of the PKC inhibitors on basal and Ang Il-stimulated
ir-endothelin-1 secretion in cultured rat mesangial cells
The stimulatory effects of Ang !I (10—v M) on the secretion of
ir-endothelin-1 were significantly inhibited by the PKC inhibi-
tors, H7 and staurosporine (Table 2). These inhibitory effects of
H7 and staurosporine were relatively dose-dependent. !n the
other hand, these PKC inhibitors did not affect the basal
secretion of ir-endothelin-l.
To confirm the importance of PKC-dependent mechanism in
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Table 2. Effects of PKC inhibitors on basal and Ang IL-stimulated
secretion of ir-endothelin- I in cultured rat mesangial cells
ir-Endothelin- I level
pg148 hr per 5 ><
cells
Baseline 10.4 1.0
H7, i0 M 10.1 0.8
Staurosporine, l0 M 9.9 1.3
Ang II, iO M 17.4 1.2°
Ang II, l0— M + H7, l0— M 11.6 1.36
Ang 11, lO M + H7, 10—6 M 12.7 11b
Ang II, l0 M + Staurosporine, iO M 10.9 1,2b
Ang II, l0— M + Staurosporine, 10—8 M 12.0 1.46
Each point represents the mean sn of 4 determinations done in
duplicate.
a P < 0.05 versus baseline
b P < 0.05 versus Ang II (l0 M) alone
the stimulation of ir-endothelin-1 secretion, the effect of PKC-
depletion was examined. PKC-depletion was made by prein-
cubation with a high dose of PMA (1O M) for 24 hours. The
secretion of ir-endothelin- 1 by PKC-depleted cells was not
increased by the addition of 1O M Ang II (Table 3).
Effects of ANP and BNP on ir-endothelin-] secretion before
and after stimulation with Ang II and on cellular cyclic GMP
levels
Rat ANP(1-28) and rat BNP-45 tended to decrease spontane-
ous ir-endothelin-1 secretion in cultured rat mesangial cells, but
not to a significant extent (Table 4).
The effects of rat ANP(l-28), rat ANP(5-25) and rat BNP-45
on ir-endothelin-l secretion in cultured mesangial cells treated
with lO M Ang II are shown in Figure IA. Rat ANP(l-28) and
rat BNP-45 inhibited the secretion of ir-endothelin-i in a
concentration-dependent manner between iO and 1O_6 M. In
cells stimulated with Ang II, in parallel with the inhibition of
ir-endothelin-l secretion, cellular cyclic GMP increased follow-
ing treatment with rat ANP(l-28) or rat BNP-45 (Fig. 1B). Rat
ANP(5-25) was less effective than the studied peptides at
inhibiting ir-endothelin-l secretion (Fig. 1A) and increasing
cyclic GMP (Fig. 1B). There was a significant inverse correla-
tion between the percent decrease in ir-endothelin- 1 secretion
and the percent increase in cyclic GMP in cultured mesangial
cells treated with lO M Ang II (Fig. 2).
Effect of sodium nitroprusside on basal and Ang lI-stimulated
ir-endothelin-1 secretion in cultured rat mesangial cells
The stimulatory effects of Ang II (1O M) on the secretion of
ir-endothelin- 1 were significantly inhibited by sodium nitroprus-
side (Table 5). On the other hand, sodium nitroprusside did not
affect the basal secretion of ir-endothelin- 1.
Effects of a cyclic GMP analogue in ir-endothelin-1 secretion
after stimulation with Ang II
To determine whether the inhibitory effect of ANP and BNP
on ir-endothelin-l secretion after stimulation with Ang II is
causally linked to the increase in cellular cyclic GMP, we
examined the effect of a cyclic GMP analogue, 8-bromo cyclic
GMP, on ir-endothelin-1 secretion. The addition of this ana-
logue at a concentration of lO or 1O M significantly reduced
Table 3. Effect of Ang II on ir-endothelin-i secretion with or without
PKC depletion in cultured rat mesangial cells
ir-Endothelin-l level
pg/48 hr per 5 x io
cells
Baseline 11.0 1.2
Ang II,
Ang II,
l0 M
iO M ÷ PKC depletion
16.7 1.0°
11.8 1,36
Each point represents the mean SD of 6 determinations done in
duplicate. To deplete PKC, the cells were preincubated with i07 M
PMA for 24 hours.
aP < 0.05 versus baselineb P < 0.05 versus Ang II (l0 M)
Table 4. Effect of rat ANP(1-28) and rat BNP-45 on spontaneous
secretion of ir-endothelin- 1 in cultured rat mesangial cells
ir-Endothel
0
in-i level (pg148 hr per 5 x l0 cells)
at peptide concentration of
1O0 108 I0_6
Rat ANP(l-28) 10.2 1.0 10.3 0.7 9.8 0.4 9.6 0.4
Rat BNP-45 10.4 0.9 10.4 1.0 9.9 0.4 9.4 0.7
Cells were exposed to different concentrations of rat ANP(l-28) or rat
BNP-45 for 48 hours at 37°C. Each point represents the mean SD of
3 determinations done in duplicate.
ir-endothelin-1 secretion after stimulation with iO M Ang II
by 25 to 35% (Fig. 3).
Discussion
We have confirmed the previous observations of Sakamoto et
al [14] and Bakris, Fairbanks and Traish [151 that cultured
mesangial cells secrete endothelin-i and found that Ang II
concentration-dependently stimulates this secretion. Endothe-
lin-l secretion by cultured vascular endothelial cells and aortas
with intact endothelium was previously found to be stimulated
by Ang II [17, 26, 27]. The amount of basal and Ang II-
stimulated endothelin-l secretion in cultured mesangial cells is
much lower than that of cultured vascular endothelial cells.
Nevertheless, the concentration of endothelin-l in the culture
media of Ang Il-stimulated mesangial cells appears to attain
levels that are within the biologically effective range for this
peptide [11].
In addition, we showed that the PKC inhibitors, H7 and
staurosporine, inhibited the Ang Il-stimulated secretion of
endothelin-1. The stimulation of endothelin-1 by Ang II is also
abolished in the PKC-depleted cells. These results suggest that
Ang II stimulates the secretion of endothelin-1 from cultured rat
mesangial cells by a mechanism probably involving activation
of PKC. However, Sakamoto et al [28] have recently demon-
strated that Ang II did not stimulate the secretion of endothe-
lin-1 in cultured rat mesangial cells. In their study, other
agonists, such as arginine vasopressin, thrombin and platelet-
derived growth factor stimulated the secretion of endothelin-l
through a PKC-dependent process. The precise reasons for the
differences in our data and the data reported by them are not
clear at present. One possibility is that added serum masked the
stimulatory effect of Ang II on endothelin-1 secretion, since
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such an effect of Ang II is considerably weaker than that of
arginine vasopressin or thrombin [28]. In our study, the effect of
Ang II on endothelin-l secretion was examined under serum-
free conditions.
The second possibility is that the number of Ang II binding
sites in cultured mesangial cells might be decreased with the
increase of passage number.
ANP was originally isolated from the mammalian heart [29,
30]. A second type of natriuretic peptide was then identified in
the porcine brain [31]; designated as BNP, it has subsequently
been isolated from porcine [32] rat [33] and human hearts [341.
ANP and BNP are both secreted through the coronary sinus
from the heart [35, 361, but ANP is secreted mainly from the
atria and BNP is secreted predominantly from the ventricles
[18, 19]. It has been suggested that ANP and BNP are involved
in the regulation of not only vascular tonus but also glomerular
function [4, 5, 7, 9, 10, 37]. In this study, we found that both rat
ANP(1-28) and rat BNP-45, which are the respective major
Table 5. Effect of sodium nitroprusside on basal and Ang II-
stimulated secretion of ir-endothelin-l in cultured rat mesangial cells
ir-Endothelin-l level
pgl48hrper5 x JO
cells
Baseline 10.9 1.6
Nitroprusside, l0- M 9.8 1.2
Nitroprusside, 1O M 10.7 1.0
Ang 11, l0 M 17.1 1.1k
Ang II, l0 M + nitroprusside, 1O M 12.0
Ang II, l0 M + nitroprusside, l0 M 12.9
circulating forms of ANP and BNP in rats [18, 19], strongly
inhibited endothelin-1 secretion stimulated by Ang II in cul-
tured rat mesangial cells. The ANP and BNP concentrations
used in the present experiment are much higher than the normal
concentration of plasma ANP and BNP in rats and humans [18,
19, 35—43]. However, during high sodium intake [44—47] or
during dynamic exercise [48—50], the level of these natriuretic
peptides increase. In particular, plasma BNP levels were found
to be higher than plasma ANP levels in patients with severe
congestive heart failure [41] and acute myocardial infarction
[51]. Furthermore, roughly 10% of cardiac output is delivered to
one kidney and a high density of ANP receptors is expressed in
glomerular mesangial cells. Therefore, ANP and BNP may
regulate the secretion of endothelin-1 induced by the potent
vasoconstrictor peptide, Ang H, in glomerular mesangial cells.
However, it remains to be clarified whether ANP and BNP have
physiological roles as modulators of endothelin-1 secretion
from glomerular mesangial cells in vivo, since not only high
concentrations of ANP and BNP are required to inhibit the Ang
II effect on endothelin-l secretion, but also high concentrations
of Ang LI are required to stimulated endothelin-l secretion in
these cells.
We have obtained three pieces of evidence for a causal link
between cyclic GMP production and inhibition of endothelin-1
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Fig. 1. A. Effect of ANP and BNP on ir-
endothelin-J secretion from cultured
mesangia! cells treated with io— M Ang II.
Cells were exposed to different concentrations
of rat ANP(l-28) (•), -(5-25) (s), or rat BNP-
45 (0) for 48 hours. *significantly difference
compared with values when neither ANP nor
BNP was added (P < 0.05). (B) Effects of
ANP and BNP on cellular cyclic GMP level in
cells stimulated with 1o— M Ang II. Cells
were exposed to different concentrations of
rat ANP(l-28) (•) or -(5-25) (LI), or rat BNP-
45 (0) for 30 minutes in the presence of 0.5
mM 3-isobytyl-1-methylxanthine. Each point is
the mean of six measurements.
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Fig. 2. Correlation between the percent decrease in ir-endothelin-l
secretion and the precent increase in cyclic GMP in cultured mesangial
cells treated with io M Ang II. Symbols are: (0) rat BNP-45; (•) rat
ANP(1-28); (LII) rat ANP(5-25). N = 9; r = 0.98; P < 0.01.
Each point represents the mean so of 4 determinations done in
duplicate.a P < 0.05 versus baseline
b p < 0.05 versus Ang II (10 M) alone
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Fig. 3. Effect of 8-bromo cyclic GMP (1O— or iO' M) on ir-endothe-
un-I secretion from cultured mesangial cells stimulated with Ang ii.
Cells were exposed to i0 or 10—' Nt 8-bromo cyclic GMP for 48 hours.
Each point is the mean of six measurements.
secretion by ANP and BNP in rat mesangial cells stimulated
with Ang II. First, rat ANP and BNP increased cyclic GMP
levels, and these effects paralleled the inhibition of endothelin-l
secretion. Second, a cyclic GMP analogue reduced Ang II-
stimulated ir-endothelin-l secretion. Third, rat ANP(5-25) had
weaker effects than rat ANP(l-28) or rat BNP-45 with respect to
inhibiting ir-endothelin-l secretion and increasing cyclic GMP
in cells stimulated with Ang II. These results suggest that ANP
and BNP inhibit Ang IT-stimulated endothelin-l secretion from
cultured rat mesangial cells through a cyclic GMP-dependent
process. Indeed, there was an inverse correlation between the
decrease in ir-endothelin-l secretion and the increase in cyclic
GMP in cultured rat mesangial cells treated with l0— M Ang II.
We also showed that nitroprusside, an activator of the cytosolic
guanylate cyclase, inhibits Ang IT-stimulated endothelin-l se-
cretion. Overall, these results suggest that both natriuretic
peptides and nitroprusside may inhibit Ang Il-stimulated secre-
tion regardless of which form of guanylate cyclase they act
upon.
Recently, Sakamoto et a! have demonstrated that either an
increase in intracellular cyclic AMP or the administration of
exogenous cyclic AMP inhibited serum-stimulated endothelin-l
production in cultured rat mesangial cells [28]. In their study,
they showed that the effect of cyclic AMP on endothelin-l
production was abolished by H-8. Therefore, other mechanisms
than cyclic GMP stimulation such as a protein kinase A-depen-
dent mechanism also inhibit endothelin-l production. Thus,
endothelin-l production in mesangial cells may be regulated by
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Appendix. Abbreviations
ANP, atrial natriuretic peptide; BNP, brain natriuretic peptide; Ang
II, angiotensin II; GMP, guanosine 5'-monophosphate; IBMX, 3-isobu-
tyl-1-methylxanthine; ir, immunoreactive; PKC, protein kinase C; and
PMA, phorbol myristate acetate.
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